PT614969E - Utilizacao de linfocitos transformados com o virus de herpes saimiri num processo para a multiplicacao de virus do tipo hiv causadores de imunodeficiencia - Google Patents

Utilizacao de linfocitos transformados com o virus de herpes saimiri num processo para a multiplicacao de virus do tipo hiv causadores de imunodeficiencia

Info

Publication number
PT614969E
PT614969E PT94102613T PT94102613T PT614969E PT 614969 E PT614969 E PT 614969E PT 94102613 T PT94102613 T PT 94102613T PT 94102613 T PT94102613 T PT 94102613T PT 614969 E PT614969 E PT 614969E
Authority
PT
Portugal
Prior art keywords
multiplication
hiv type
type viruses
lymphocytes transformed
herpes saimiri
Prior art date
Application number
PT94102613T
Other languages
English (en)
Inventor
Bernard Fleckenstein
Gerhard Jahn
Sigrid Nick
Helmut Fickenscher
Brigitte Biesinger-Zwosta
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT614969E publication Critical patent/PT614969E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16611Simplexvirus, e.g. human herpesvirus 1, 2

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT94102613T 1993-03-12 1994-02-22 Utilizacao de linfocitos transformados com o virus de herpes saimiri num processo para a multiplicacao de virus do tipo hiv causadores de imunodeficiencia PT614969E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4307970A DE4307970A1 (de) 1993-03-12 1993-03-12 Verwendung von mit Herpesvirus saimiri transformierten Lymphozyten in einem Verfahren zur Vermehrung von Immunschwäche verursachenden Viren vom HIV-Typ

Publications (1)

Publication Number Publication Date
PT614969E true PT614969E (pt) 2002-05-31

Family

ID=6482679

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94102613T PT614969E (pt) 1993-03-12 1994-02-22 Utilizacao de linfocitos transformados com o virus de herpes saimiri num processo para a multiplicacao de virus do tipo hiv causadores de imunodeficiencia

Country Status (10)

Country Link
US (1) US5656475A (pt)
EP (1) EP0614969B1 (pt)
JP (1) JPH06319544A (pt)
AT (1) ATE209676T1 (pt)
AU (1) AU669422B2 (pt)
CA (1) CA2118843A1 (pt)
DE (2) DE4307970A1 (pt)
DK (1) DK0614969T3 (pt)
ES (1) ES2168279T3 (pt)
PT (1) PT614969E (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5765172A (en) * 1996-01-23 1998-06-09 Dsc Communications Corporation System and method for verifying integrity of replicated databases
DE59710091D1 (de) 1997-07-11 2003-06-18 Fleckenstein Bernard Von Kaposi-sarkom assoziiertem Herpes-Virus (KSHV, HHV-8) kodiertes Polypeptid und dessen Verwendung in Diagnostik und Therapie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990004020A1 (en) * 1988-10-06 1990-04-19 Dana Farber Cancer Institute H. saimiri-htlv-x region vector

Also Published As

Publication number Publication date
DK0614969T3 (da) 2002-03-18
CA2118843A1 (en) 1994-09-13
US5656475A (en) 1997-08-12
ATE209676T1 (de) 2001-12-15
EP0614969B1 (de) 2001-11-28
EP0614969A3 (en) 1995-11-15
DE4307970A1 (de) 1994-09-15
EP0614969A2 (de) 1994-09-14
DE59409970D1 (de) 2002-01-10
AU5773194A (en) 1994-09-15
AU669422B2 (en) 1996-06-06
ES2168279T3 (es) 2002-06-16
JPH06319544A (ja) 1994-11-22

Similar Documents

Publication Publication Date Title
ATE129160T1 (de) Herpes-simplex-impfstoff, der hsv-glycoprotein-gd und 3-deacyl monophosphoryl-lipid-a enthaelt.
PL336168A1 (en) Pharmaceutic composition protecting against micro-organisms in particular hiv and herpes viruses
CA2052235A1 (en) Snow rake
ES2110635T3 (es) Hoja de sierra con cuerpo base y dientes sin triscado.
EP0573365A3 (en) Printing plates for flexographic printing with antistatic views based on vanadia oxide.
DE69129207T2 (de) Peptide, von Virus-HIV-Hüllen-Glycoproteinen abstammend, deren Verwendung zum Nachweis einer Infektion dieser Viren und für die Impfung gegen AIDS
CA2183688A1 (en) Synthetic resin bottle with grip
PT614969E (pt) Utilizacao de linfocitos transformados com o virus de herpes saimiri num processo para a multiplicacao de virus do tipo hiv causadores de imunodeficiencia
GR3032767T3 (en) Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines.
AR009092A1 (es) Un procedimiento para preparar 2'-fluoro-5-metil-beta-l- arabinofuranosiluridina.
OA09819A (fr) Utilisation de la riboflavine dans le taitement de maladies liées aux virus hiv de l'herpès de la rétinite pigmentaire et du paludisme
BR9100019A (pt) Processo para a preparacao de um catalisador do tipo ziegler-natta baseado em compostos de vanadio e titanio e utilizacao desse catalisador
NO940810L (no) Behandling av virusinfeksjoner
AU4037793A (en) Treatment of herpesvirus infection
PT91251A (pt) Molde para uma embalagem multipla e processo para a embalagem de um grupo de recipientes utilizando este molde
BR9504415A (pt) Pinça de conexao e dispositivo com pinça de conexao
CY2008005I2 (el) Εμβολιο κατα της παρωτιτιδας που περιεχει στελεχος ιου jeryl-lynn
AU3188993A (en) Soluble ldl receptor, its production and use
BR9404159A (pt) Processo para a polimerização por radical de cloreto de vinila
ZA935122B (en) Anti-feline immunodeficiency virus (FIV) vaccines
BR9105340A (pt) Composicao ingerivel contendo ion fluoreto isenta de fluorose e aperfeicoamento em um processo para evitar ou minimizar a formacao de manchas nos dentes de criancas
MX9206973A (es) Vacuna a base de virus del herpes bovino modificado tipo 1.
AU7104194A (en) High yielding influenza viruses
PT973543E (pt) Processo para desactivar patogenicos em especial virus num material biologico
AU3512793A (en) Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use